Clinical trial Recruiting at 1 site Interventional Ages 18 to 70

Using brain stimulation to help patients with autoimmune muscle diseases

Official title: Chronic Transcranial Direct Current Stimulation in Patients With Systemic Autoimmune Myopathies

Run by University of Sao Paulo · NCT04678635 · Data updated 2026-11-12

This study is testing if a new brain stimulation treatment combined with exercise can help people with autoimmune muscle diseases feel stronger and improve their quality of life.

Quick facts

Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment40 (estimated)
SponsorUniversity of Sao Paulo
Academic / other
Locations1 site (São Paulo, São Paulo)
StatusRecruiting
StartedDecember 12, 2020
Main results expectedMay 6, 2024
Study endsDecember 4, 2024
Registry record updatedDecember 9, 2024
Trial IDNCT04678635 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals diagnosed with systemic autoimmune myopathies who meet specific classification criteria.

Probably not a fit

Patients with neoplasia, heart pacemakers, visceral metallic clips, infections, pregnancy, or a history of seizures or epilepsy may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the safety and efficacy of chronic transcranial direct current stimulation combined with aerobic exercises in patients suffering from systemic autoimmune myopathies. These conditions lead to significant muscle weakness and functional disability, and the study aims to explore a novel therapeutic approach that has not been previously tested in this patient population. It is a prospective, randomized, double-blind, placebo-controlled design, ensuring rigorous assessment of the intervention's effects. The goal is to determine if this technique can improve muscle function and overall quality of life for affected individuals.

Why it matters

Potential benefit: If successful, this approach could significantly enhance muscle recovery and functional ability in patients with systemic autoimmune myopathies.

How similar studies have gone: While transcranial direct current stimulation has shown promise in other conditions, this specific application in systemic autoimmune myopathies is novel and untested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Classification criteria - EULAR/ACR 2017
* Classification critera - Connors et al.

Exclusion Criteria:

* Neoplasia
* Using heart pacemarker
* Using visceral metalic clips
* Infections (HIV, HTLV-1, Hepatitis, etc)
* Pregnance
* Previous historical of convulsions or epilepsies

Where it's running

  • Samuel K Shinjo
    São Paulo, São Paulo, Brazil
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.